MedTrace Logo

The InterVitaminK Trial - Effects of Vitamin K Supplementation on Cardiovascular, Metabolic, and Bone Health

NCT05259046 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 450

Last updated 2026-02-17

No results posted yet for this study

Summary

The purpose of this study is to examine the effect of menaquinone-7 (MK-7) supplementation on cardiovascular, metabolic, and bone health.

Conditions

  • Coronary Artery Calcification
  • Arterial Stiffness

Interventions

DIETARY_SUPPLEMENT

Menaquinone-7 (MK-7) tablet (333 µg)

One MK-7 tablet containing 333 µg MK-7 per day

DIETARY_SUPPLEMENT

Placebo tablet

One placebo tablet per day

Sponsors & Collaborators

  • Bispebjerg Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-21
Primary Completion
2027-01-30
Completion
2027-02-28

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05259046 on ClinicalTrials.gov